EXT2 and Multiple osteochondromas: In the Western population, mutations in the EXT1 and EXT2 genes are responsible for 40%~75% and 20%–40% of HMO cases, respectively [3–5], compared with 14~53% and 33% ~40% in the Chinese population, respectively [6, 7].